Rising expectations: Health and nutrition drive ‘strong’ Q3 for Chr Hansen

By Nathan Gray

- Last updated on GMT

Rising expectations: Health and nutrition drive ‘strong’ Q3 for Chr Hansen

Related tags Chr hansen Bacteria

Probiotic and natural colours player Chr Hansen reported a 10% growth in organic revenue in the first nine months, leading the company to slightly raise full year expectations.

CEO Cees de Jong said a ‘better than expected’ performance in both Food Cultures & Enzymes and Health & Nutrition led to a ‘strong’ third quarter and nine-month result – meaning the company has narrowed organic revenue expectations from a previously suggested 8%-10% to a new estimate of 9%-10%.

“Both Food Cultures & Enzymes and Natural Colors delivered further improvements in profitability, while Health & Nutrition showed a solid margin progression in Q3,” ​said de Jong. “The capacity expansion for dairy cultures in Copenhagen is on track, and we are preparing for the final implementation later this year.”

Chr Hansen reported year-to-date (YTD) revenue of €780 million, compared to €693 million for the same period last year. Profits were up by €28 million – hitting €156m versus €128m in 2015/16.

Driving the increased revenue was 12% organic growth for the firm’s Health & Nutrition division, while Food Cultures & Enzymes and Natural Colours groups both reported a 9% organic growth.

Microbiome growth

de Jong added that the company has seen great growth and a strong performance in its human microbiome program including the recent addition of 100 new strains to its development library​, which could help development of new commercial probiotics for a range of metabolic, immune, and digestive health issues.

“It is exciting to see that we are making solid progress in the area of the human microbiome, where we have recently expanded our strain library with lead candidates targeting gastrointestinal, immune and metabolic health,” said the CEO.

“Adding these novel bacterial strains to our portfolio is a major milestone in developing the next-generation probiotics.”

Related news

Related products

show more

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Related suppliers

Follow us


View more